1. Home
  2. Analysis
  3. Gemcitabine
  4. Multiple-sclerosis

Gemcitabine and Multiple sclerosis - a phase IV clinical study of FDA data

Summary:

Multiple sclerosis is reported as a side effect among people who take Gemcitabine (gemcitabine), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Oxaliplatin, and have Non-hodgkin's lymphoma.

The phase IV clinical study analyzes which people have Multiple sclerosis when taking Gemcitabine. It is created by eHealthMe based on reports of 31,291 people who have side effects when taking Gemcitabine from the FDA, and is updated regularly.

What is Gemcitabine?

Gemcitabine has active ingredients of gemcitabine. eHealthMe is studying from 31,337 Gemcitabine users. Check the latest studies of Gemcitabine.

What is Multiple sclerosis?

Multiple sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath) is found to be associated with 1,086 drugs and 1,364 conditions by eHealthMe. Check the latest studies of Multiple sclerosis.

On Jul, 11, 2026

31,291 people reported to have side effects when taking Gemcitabine.
Among them, 13 people (0.04%) have Multiple sclerosis.

Could Gemcitabine cause Multiple sclerosis?

Among these 13 people:

How long have people been on Gemcitabine when they have Multiple sclerosis? *

  • < 1 month: 100 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the gender of people who have Multiple sclerosis when taking Gemcitabine? *

  • female: 27.27 %
  • male: 72.73 %

What is the age of people who have Multiple sclerosis when taking Gemcitabine? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 40 %
  • 50-59: 20 %
  • 60+: 40 %

What are other drugs people take besides Gemcitabine? *

  1. Cisplatin: 7 people, 53.85%
  2. Etoposide: 7 people, 53.85%
  3. Dexamethasone: 7 people, 53.85%
  4. Oxaliplatin: 7 people, 53.85%
  5. Vincristine Sulfate: 6 people, 46.15%
  6. Carmustine: 6 people, 46.15%
  7. Cytarabine: 6 people, 46.15%
  8. Cyclophosphamide: 6 people, 46.15%
  9. Prednisolone: 6 people, 46.15%
  10. Melphalan: 6 people, 46.15%

What are other side effects people have besides Multiple sclerosis? *

  1. Osteolysis (dissolution of bone): 6 people, 46.15%
  2. Lymph Follicular Hypertrophy (an increase in the size of the lymph node follicles): 6 people, 46.15%
  3. Metastases To Chest Wall (cancer spreads to chest wall): 6 people, 46.15%
  4. Diffuse Large B-Cell Lymphoma Recurrent (recurrent cancer of b cells, a type of white blood cell): 6 people, 46.15%
  5. Peritoneal Lesion: 6 people, 46.15%
  6. Pneumonia: 3 people, 23.08%
  7. Hypoaesthesia (reduced sense of touch or sensation): 3 people, 23.08%
  8. Fever: 3 people, 23.08%
  9. Osteosclerosis (an elevation in bone density): 3 people, 23.08%
  10. Weakness: 3 people, 23.08%

What are the existing conditions these people have? *

  1. Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 7 people, 53.85%
  2. Diffuse Large B-Cell Lymphoma Recurrent (recurrent cancer of b cells, a type of white blood cell): 6 people, 46.15%
  3. Nausea (feeling of having an urge to vomit): 2 people, 15.38%
  4. Sleep Disorder: 1 person, 7.69%
  5. Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 1 person, 7.69%
  6. Pancreatic Carcinoma (pancreatic cancer): 1 person, 7.69%
  7. Pain: 1 person, 7.69%
  8. Neurilemmoma Malignant (a cancer tumour that typically grows on the myelin sheath of nerves in the head or neck): 1 person, 7.69%
  9. Neoplasm Malignant (cancer tumour): 1 person, 7.69%
  10. Metastatic Carcinoma Of The Bladder (cancer types can spread to the bladder from other place): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Gemcitabine and have Multiple sclerosis?

- Check whether Multiple sclerosis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Gemcitabine:

Multiple sclerosis treatments and more:

How severe was Multiple sclerosis and when was it recovered:

Expand to all the drugs that have ingredients of gemcitabine:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Gemcitabine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Multiple sclerosis:

Browse all the conditions that are associated with Multiple sclerosis:

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on gemcitabine (the active ingredients of Gemcitabine) and Gemcitabine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.